Skip to content
Home/Companies/Software/Protera
Protera

Protera

Software·US·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Protera?

Protera is currently owned by Sofinnova Partners through Sofinnova Industrial Biotech (2018 vintage), since 2020.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC

Key facts

HQUSA
SectorSoftware
Websitewww.proterabio.com

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

Arzeda
Arzeda
Active
BiotechUS· 2022
IB Works I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Novameat
Active
BiotechSpain· 2021
Qorium
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Protera

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Protera?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Protera.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue